Latest news and insights on the pharmaceutical industry | Indian Pharma Post

Results For "SB27"

1 News Found

Samsung Bioepis’ Pembrolizumab biosimilar SB27 meets phase 1 PK endpoints
Biopharma | May 06, 2026

Samsung Bioepis’ Pembrolizumab biosimilar SB27 meets phase 1 PK endpoints

The proposed biosimilar to Keytruda demonstrated pharmacokinetic bioequivalence in a multicountry Phase 1 study involving non-small cell lung cancer patients